Hologic’s fetal fibronectin testing to assess the possibility of preterm birth has been available to obstetricians and gynecologists for years. But what physicians have not had was a quantifiable method for determining the likelihood of a preterm birth. DDCworks developed a comprehensive creative platform— ads, collateral, physician tools and more—to tell this story across Europe.


(Side Note: As a leading member of ICOM, the world’s largest network of independent agencies, with member partners in 75 countries and 87 cities around the globe, we’ve got the global marketing connections and capability that you may need.)